Black Hills Cardiovascular Research Awarded Grant, Now Seeking Patients for Heart Attack Study
Black Hills Cardiovascular Research (BHCR) received a grant from AstraZeneca for $390,500. The grant enables BHCR to seek participants for a clinical research study called RELATE. The objective of RELATE is to compare the antiplatelet effects of two platelet inhibitors, ticagrelor and clopidogrel, in American Indians who have had a heart attack at least one year ago and are on a low dose of aspirin.
RELATE will explore the platelet inhibiting effects of ticagrelor and clopidogrel in Native American patients with stable coronary artery disease, specifically looking at day one and day seven platelet inhibiting effects.
James S. Walder, M.D., FACC, Cardiologist and the Principal Investigator for this research study explains, “Since we now know that drugs work differently in the body based on one’s genetics, medicine is now being studied in certain ethnic groups (Japanese, Hispanic/Latino, African-American). Roger DeRaad, CNP and our Director of Research at BHCR, wrote this research study to include another important ethnic group in our Black Hills community, the Native American population.”
To participate in this study you must be a male or female Native American age 18 years or older, have documented stable coronary artery disease and be taking 75-100 mg of aspirin daily.
If you or someone you know is interested in this clinical research study, call Franco Garcia, BHCR Clinical Research Coordinator, at (605) 718-6296 for more information. For more information on all Regional Health research studies, log on to www.regionalhealth.com/research.